查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
肠道管理系统市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)
市场调查报告书
商品编码
1190134

肠道管理系统市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Bowel Management Systems Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，肠道管理系统市场的复合年增长率预计为 3.3%。

在 COVID-19 大流行期间，因 COVID-19 感染而增加的其他健康并发症也在增加。 2022 年 1 月的冠状病毒监测流行病学研究排除 (SECURE-IBD) 数据库报告发现，COVID-19 不良事件与 IBD 患者的年龄和其他合併症有关。 新型严重急性呼吸系统综合症相关冠状病毒在进入胃肠道后会启动先天性和适应性免疫反应的激活。 炎症反应的表达被认为会导致 IBD 患者的肠道疾病。 根据 2020 年 10 月世界胃肠病学杂誌的一篇评论，发现许多 COVID-19 患者出现胃肠道不适。 因此，对肠道管理系统的需求不断增长，以管理因 COVID-19 感染可能引起的进一步并发症。 然而，在大流行后时期，全球范围内解除限制限制预计将推动对肠道管理系统的需求。

推动市场增长的关键因素是炎症性肠病发病率上升和技术不断进步。 事实证明，全球越来越多的老年人口容易出现便秘、腹泻和其他肠道疾病，这有助于推动肠道管理系统市场的发展。 例如，根据CDC在2021年4月（5月19日）世界IBD日发布的报告，2020年全球将有大约700万IBD患者。

IBD 患者患癌症、关节炎、偏头痛和其他心血管、呼吸系统、肾臟和肝臟疾病等慢性疾病的患病率高于非 IBD 患者。 根据上述资料，我们发现在老年人（64 岁及以上）中，IBD 患者更有可能因髋部骨折住院。 我们还发现 30 天再入院和住院时间更长。 因此，预计老年人口的再入院风险将推动对肠道管理系统的需求，并有助于预测期内的市场增长。

此外，肠道管理系统对脊髓损伤、多发性硬化症、帕金森氏病、阿尔茨海默氏病、脑肿瘤、慢性便秘、卧床不起的患者以及无法正常排便的儿童等神经系统疾病患者的有效性. 业绩有望提振市场增长。

因此，上述因素预计将在预测期内推动市场增长。

肠道管理系统市场趋势

结肠造口袋细分市场有望占据肠道管理系统市场最大份额

肠易激综合症、多发性硬化症、克罗恩病和癌症等肠道疾病的高发病率和相关健康并发症已导致结肠造口袋部分在市场上占据主导地位。预计将占据很大的市场份额。 因此，结肠造口袋市场预计将受到慢性病患病率上升的推动。

克罗恩病是炎症性肠病 (IBD) 的一种形式，可影响从口腔到肛门的胃肠道的任何部分，推动结肠造口袋段。 根据克罗恩病和结肠炎组织在 2022 年发表的一篇文章，英国每年每 123 人中就有 1 人患有克罗恩病。

此外，增加产品开发和临床试验预计将有助于增加对结肠造口袋的需求，从而促进研究部门的增长。 例如，2021 年 12 月，Coloplast 启动了一项临床试验，以测试 Heylo 的有效性，Heylo 是一种使用传感器警告患者结肠造口袋洩漏并建议他们如何防止洩漏的产品。。

因此，上述因素预计将在预测期内推动所研究细分市场的增长。

北美主导市场，预计在预测期内也会如此

在预测期内，预计北美将主导肠道管理系统市场。 这是由于结直肠癌患病率上升和人口老龄化等因素造成的。 然而，根据美国癌症协会的数据，到 2022 年 1 月，大约每 23 名男性中就有 1 名终生有患结直肠癌的风险，每 25 名女性中就有 1 名将成为风险因素。 此外，患者认知度的提高、肠道管理系统采用率的提高、产品开发投入的增加、优秀医疗基础设施的建立、开发产品的接受度高也是确保该地区优势地位的主要因素之一。 .

例如，2021年7月，造口专业製造商Trio Healthcare从美国金融公司SWK Holdings Inc.获得了约1000万美元的第二轮融资，用于生产Trio的造口袋“Genii”。我们已经筹集了资金.

因此，上述因素预计将在预测期内推动该地区的增长。

肠道管理系统市场竞争分析

肠道管理系统市场本质上是高度分散的，因为存在多家在全球和区域运营的公司。 从市场份额的角度来看，目前几家大型企业占据了市场主导地位。 目前主导市场的公司包括 Medtronic PLC、Becton Dickinson and Company、B. Braun Melsungen AG、Coloplast Pty Ltd 和 ConvaTec Inc。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 炎症性肠病的高发率
    • 老年人口增加
  • 市场製约因素
    • 患者越来越喜欢非侵入性治疗
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按产品分类
    • 结肠造口袋
    • 灌溉系统
    • 神经调节装置
    • 其他产品
  • 按患者类型
    • 成人
    • 儿科
  • 最终用户
    • 医院
    • 门诊
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Medtronic PLC
    • Becton, Dickinson and Company
    • B. Braun Melsungen AG
    • Coloplast Pty Ltd
    • ConvaTec Group PLC
    • Consure Medical Pvt. Ltd
    • Cogentix Medical
    • Hollister Incorporated
    • ABC Medical Supply Inc.
    • Laborie Inc.

第7章 市场机会今后动向

简介目录
Product Code: 67868

The bowel management systems market is anticipated to register a CAGR of 3.3% during the forecast period.

Amidst the outbreak of the COVID-19 pandemic, there has been a rise in other health complications that rose with COVID-19 infections. According to a report by the Surveillance Epidemiology of Coronavirus Under Research Exclusion (SECURE-IBD) database in January 2022, adverse COVID-19 outcomes were associated with age and other co-morbidities among patients with IBD. The novel severe acute respiratory syndrome-related coronavirus initiates activation of innate and adaptive immune responses upon entering the gastrointestinal tract. The onset of inflammatory reactions can supposedly induce intestinal damage in IBD patients. As per a review article in the World Journal of Gastroenterology in October 2020, it was comprehended that many COVID-19 patients were found to develop gastrointestinal complaints. Thus, there is an increasing demand for bowel management systems to manage further complications that could develop due to COVID-19 infection. However, the relaxation of the lockdown restrictions during the post-pandemic period is expected to drive the demand for the bowel management system due to the lifting of lockdowns across the world.

The significant factor attributing to the market's growth is the rising incidence of inflammatory bowel diseases and increasing technological advancement. The increasing geriatric population across the world is found to be more prone to constipation, diarrhea, and other bowel conditions that help to drive the bowel management systems market. For instance, according to a report by the CDC, published in April 2021 on World IBD Day (May 19), the number of people affected by IBD around the world was approximately 7 million in 2020.

The prevalence of chronic health conditions, such as cancer, arthritis, migraine, and other cardiovascular, respiratory, kidney, and liver diseases, are higher in IBD patients than in non-IBD patients. As per the source mentioned above, in the older population (above 64 years), patients with IBD were more susceptible to hospitalization for hip fractures. Also, they were found to have 30-day readmissions and longer hospital stays. Hence, the readmission risks among the elderly population are expected to drive the demand for bowel management systems, thereby contributing to the market's growth over the forecast period.

It also indicated the efficacy of bowel management systems in people with neurological disorders, such as spinal cord injury, multiple sclerosis, Parkinson's disease, Alzheimer's disease, brain tumors, chronic constipation, bedridden patients, and children unable to pass stool regularly, and properly, are expected to boost the growth of the market.

Thus, the above-mentioned factors are expected to drive the market's growth during the forecast period.

Bowel Management Systems Market Trends

Colostomy Bags Segment is Expected to Hold the Largest Market Share in the Bowel Management Systems Market

The colostomy bags segment is expected to hold the dominant share in the market, owing to the factors such as high incidence rates and health complications associated with bowel diseases, such as irritable bowel syndrome, multiple sclerosis, Crohn's disease, and cancer. The market for colostomy bags is therefore expected to be driven by the rising incidence of chronic diseases.

Crohn's disease is a form of inflammatory bowel disease (IBD) that can impact any portion from the mouth to the anus of the gastrointestinal tract, which boosts the colostomy bag segment. As per the article published in 2022 by Crohn's and Colitis Organization, one in every 123 people in United Kingdom has had Crohn's disease annually.

Also, the increasing product developments and clinical trials are expected to contribute to the growing demand for colostomy bags, thereby boosting the growth of the studied segment. For instance, in December 2021, Coloplast launched a clinical trial to test the effect of its ostomy product, Heylo, a product that uses sensors to warn patients with colostomy bags about leakage and advise them about how to prevent it.

Thus, the above-mentioned factors are expected to drive the growth of the studied segment during the forecast period.

North America is Expected to Dominate the Market and is Expected to do Same in the Forecast Period

North America is expected to dominate the bowel management systems market over the forecast period. This is owing to factors such as the rising prevalence of colorectal cancer and the growing geriatric population. However, according to the American Cancer Society, in January 2022, about one in 23 males was at a lifetime risk of developing colorectal cancer, and the risk factor among women was one in 25. Additionally, increased patient awareness, rising adoption rates of intestinal management systems, increasing investments in product development, excellently-established healthcare infrastructure, and strong acceptance of developed products are also some of the key factors ensuring the dominance of the region.

For instance, in July 2021, the Ostomy Specialist Trio Healthcare secured a second round of funding from US finance company SWK Holdings corporation of approximately USD 10 million in total for manufacturing Trio's stoma bags, Genii.

Thus, the above-mentioned factors are expected to drive the growth of the region during the forecast period.

Bowel Management Systems Market Competitive Analysis

The bowel management systems market is considerably fragmented in nature due to the presence of several companies operating globally as well as regionally. In terms of market share, a few of the major players are currently dominating the market. Some of the companies, which are currently dominating the market, are Medtronic PLC, Becton Dickinson and Company, B. Braun Melsungen AG, Coloplast Pty Ltd, and ConvaTec Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Incidence of Inflammatory Bowel Disease
    • 4.2.2 Rising Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 Patient's Greater Preference for Non-invasive Treatment
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Colostomy Bags
    • 5.1.2 Irrigation Systems
    • 5.1.3 Nerve Modulation Devices
    • 5.1.4 Other Products
  • 5.2 By Patient Type
    • 5.2.1 Adults
    • 5.2.2 Paediatric
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic PLC
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 B. Braun Melsungen AG
    • 6.1.4 Coloplast Pty Ltd
    • 6.1.5 ConvaTec Group PLC
    • 6.1.6 Consure Medical Pvt. Ltd
    • 6.1.7 Cogentix Medical
    • 6.1.8 Hollister Incorporated
    • 6.1.9 ABC Medical Supply Inc.
    • 6.1.10 Laborie Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS